Pfenex Revenue and Competitors

Location

$63.4M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Pfenex's estimated annual revenue is currently $35M per year.(i)
  • Pfenex's estimated revenue per employee is $2,058,824
  • Pfenex's total funding is $63.4M.

Employee Data

  • Pfenex has 17 Employees.(i)
  • Pfenex grew their employee count by -11% last year.

Pfenex's People

NameTitleEmail/Phone
1
VP Finance and ControllerReveal Email/Phone
2
Director, Purification Development and Lab OperationsReveal Email/Phone
3
Associate Director, Product Development LeaderReveal Email/Phone
4
Director Manufacturing / Technology TransferReveal Email/Phone
5
Chief Financial OfficerReveal Email/Phone
6
Director, Portfolio DevelopmentReveal Email/Phone
7
Scientist-Downstream ProcessingReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$69340M1073104%N/A$308.4B
Add Company

What Is Pfenex?

Headquartered in San Diego, California, Pfçnex Inc. is a leading biotechnology company focused on recombinant protein expression for a broad range of applications including therapeutic proteins, vaccines, research, reagents and biosimilars. The Company's core technology, Pfçnex Expression Technology™, is a cutting edge protein expression platform that utilizes the BSL-1 microorganism Pseudomonas fluorescens. Pfçnex Expression Technology™ combines an extensive toolbox of expression components with a robotically enabled high throughput parallel strain screening technology, delivering unprecedented speed and success in identifying protein production strains expressing high titers of soluble active protein

keywords:N/A

$63.4M

Total Funding

17

Number of Employees

$35M

Revenue (est)

-11%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Pfenex News

2022-04-20 - Chemotherapy Induced Neutropenia Drug Market Business ...

... Pangen Biotech Inc., Pfenex Inc, Pfizer Inc, Reliance Life Sciences Pvt Ltd, Richter Gedeon Nyrt, Sandoz International GmbH, USV Pvt Ltd.

2022-04-17 - Retinal Biosimilars Market Global Industry Research Analysis ...

Shire; Bayer; Genentech; Pfenex; Reliance Life Sciences; Hetero Drugs; Intas Pharmaceuticals; Santo Holding; Regeneron Pharmaceuticals. The...

2022-03-22 - Global Pharma, Biotech and Diagnostics Joint Venture ...

... Deal Terms and Agreements Analysis Report 2021 with Example Case Studies of Agila Specialties/Pfenex and Dance Biopharm/Harmony Asset.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.8M176%$21.4M
#2
$3.6M17N/AN/A
#3
$1.5M17N/AN/A
#4
$1.5M17N/AN/A
#5
$1.5M17N/AN/A